CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
796-810 of 1225

Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®Optimizing AAV Outcomes: Maintenance Therapies

Don't Miss It! Rapid & Accurate AAV Diagnosis
MinuteCE®Don't Miss It! Rapid & Accurate AAV Diagnosis

Patient Case Study: Cancer-Associated Thrombosis
MinuteCE®Patient Case Study: Cancer-Associated Thrombosis

GA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
CME/CEGA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
- advertisement

Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CEAdvancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow

Emerging Data in HER2-Targeted ADCs for Metastatic Breast Cancer
MinuteCE®Emerging Data in HER2-Targeted ADCs for Metastatic Breast Cancer

Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
MinuteCE®Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases

Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC
MinuteCE®Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC

Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer
MinuteCE®Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer

HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
MinuteCE®HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
- advertisement

Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer
MinuteCE®Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer

Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
MinuteCE®Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches




































